Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Gross Margin (2018 - 2025)

Dna X's Gross Margin history spans 8 years, with the latest figure at 11.2% for Q3 2025.

  • Quarterly results put Gross Margin at 11.2% for Q3 2025, down 1697.0% from a year ago — trailing twelve months through Sep 2025 was 16.23% (down 1060.0% YoY), and the annual figure for FY2024 was 17.02%, down 362.0%.
  • Gross Margin for Q3 2025 was 11.2% at Dna X, up from 7.55% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 49.97% in Q1 2025 to a low of 3.06% in Q4 2021.
  • The 5-year median for Gross Margin is 16.49% (2023), against an average of 18.41%.
  • The sharpest move saw Gross Margin crashed -3893bps in 2024, then skyrocketed 3267bps in 2025.
  • Year by year, Gross Margin stood at 3.06% in 2021, then soared by 633bps to 16.3% in 2022, then surged by 134bps to 38.12% in 2023, then plummeted by -102bps to 0.81% in 2024, then skyrocketed by 1486bps to 11.2% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 11.2%, 7.55%, and 49.97% for Q3 2025, Q2 2025, and Q1 2025 respectively.